Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
This blog post is for informational purposes only
Crohns disease is another type of IBD
900/-, MRP : 2986 /- Recommended Dosage for Glutathione Injections: When it comes to taking glutathione injections for skin whitening, the dosage is a critical factor
Not because telehealth is more convenient than seeing a local endocrinologist
How soon before a holiday event should someone start semaglutide for noticeable results